Study found: older patients risk death on BOTH old and new Antipsychotics

Study found: older patients risk death on BOTH old and new Antipsychotics Thu, 01 Dec 2005 Elderly patients prescribed antipsychotics–old neuroleptics (such as Haldol) or the new antipsychotics (such as Zyprexa or Risperdal)–were at increased risk of death. The risk for the older drugs is estimated to be 17.9%  and…

NYS Hearing –AIDS Drug /Vaccine Experiments on Foster Children

Testimony by Vera Hassner Sharav, President ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org Hearing of the NYS Assembly Committee on Health and Committee on Children and Families September 8, 2005 New York City I speak on behalf of the ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP), the organization that filed the…

Prozac in Drinking Water / Prozac in Streams Hurt Frogs fish / Newborns suffer Withdrawal

Prozac in Drinking Water / Prozac in Streams Hurt Frogs fish / Newborns suffer Withdrawal Tue, 10 Aug 2004 An article in the UK Observer–“Stay calm everyone, there’s Prozac in the drinking water” (below) — reports that British environmentalists are calling for an “urgent investigation into the revelations, describing the…

AHRP Comments Re: Best Pharmaceuticals for Children’s Act of 2002

Comments submitted by The Alliance for Human Research Protection Re: Best Pharmaceuticals for Children’s Act of 2002 The National Academy of Sciences Committee of the Institute of Medicine on Clinical Research Involving Children August 18, 2003 Vera Hassner Sharav, President John H. Noble, Jr., Ph.D, Treasurer David Cohen, Ph.D, Secretary…

Best Pharmaceuticals for Children Act of 2002


Comments submitted by The Alliance for Human Research Protection
to The National Academy of Sciences
Committee of the Institute of Medicine on Clinical Research Involving Children

AHRP has been closely monitoring pediatric research trends since passage of the FDA Modernization Act of 1997. We believe that medications used in children should be thoroughly tested for safety, effectiveness and appropriate dose. But unlike adults who can exercise their autonomous right to informed consent, children who are enrolled in clinical trials are non-consensual human subjects. They should not, therefore, be made to assume the burden of testing possibly toxic drugs whose safety is unknown.

|

American Eugenics: Bad Seed or Bad Science?

American Eugenics: Bad Seed or Bad Science? Sat, 8 Feb 2003 The New York Times reports: “For more than a century, the Juke clan was presented as America’s most despised family.” The Jukes family was categorized by social scientists as “congenital misfits, criminals, harlots, epileptics and mental defectives.” But the…

FDA: Regulatory Protections for Children

Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Howard Fishman, MEd, MSW for AHRP

To: Dr. Bernard Schwetz Acting Commissioner Food and Drug Administration, Dockets Management Branch (HFA-305) Food and Drug Administration

Re: COMMENT ON: Docket #00N-0074 April 24, 2001 Interim Rule: "Additional Safeguards for Children in Clinical Investigations of FDA-Regulated Products

Excerpt: The FDA rightly chose not to permit the section 46.408 (c) waiver by IRBs of parental or guardian permission, as it leaves the specific circumstances for such a violation of parental rights to the discretion of local Institutional Review Boards (IRB). Given the stream of revelations of gross ethical and procedural violations at one after another of the nation’s premier research institutions, assumptions that “procedural safeguards are in place,” or that IRBs can be relied upon to make decisions that protect the best interests of human subjects – adults and children – has been debunked.

|

Psychiatric Researchers Under Fire — NY Times, May 19, 1998

The New York Times May 19, 1998 Psychiatric Researchers Under Fire By PHILIP J. HILTS ANDREW BROWNSTEIN, a severe manic-depressive, was desperate. None of his medicines could keep the anxiety and depression of his illness at bay. So in the fall of 1994, he agreed to become a research subject…